Evidence map›Paper›PMID 28982688›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.

Kumardeep Chaudhary, Olivier B Poirion, Liangqun Lu, Lana X Garmire

Registry-linked trialAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06245694 (Predictive and Advanced Analytics in Emergency Medicine - Neurological Deficits), which is not on this map. Cited by 507 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
507citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06245694 recruitingnot on this mapstarted 2022, after this paper: background citation

Predictive and Advanced Analytics in Emergency Medicine - Neurological Deficits

TypeobservationalSponsorMedical University of ViennaRan2022 to 2030Enrolled50,000ConditionsArtificial Intelligence, Resource Allocation, Neurologic Manifestations
3 · Its place in the literature

Who cites it

507 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Target identification and assessment in the era of AI.Nature reviews. Drug discovery · 2026
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. CSIE: cancer subtyping via inference and ensemble.Briefings in bioinformatics · 2026
    Article
  19. Article
  20. Article

447 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kumardeep Chaudhary *Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Olivier B Poirion *Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Liangqun LuEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Lana X GarmireEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii. lgarmire@cc.hawaii.edu.

Funding

Transgenic Mouse, ICSI and IVF CoreP20GM103457 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI URSCHITZ, JOHANN · 2012 to 2018
$12.9M
Translational Pilot Project ProgramP30GM131944 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI WARD, WILLIAM S · 2019 to 2023
$5.9M
An Integrative Omics Approach to Identify Biomarkers Related to Preeclampsia and Breast Cancer RisksR01HD084633 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GARMIRE, LANA X · 2016 to 2020
$3.0M
Cancer precision medicine through spatially informative single cell image and transcriptomics data analysisR01LM012373 · NLM · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GARMIRE, LANA X · 2016 to 2024
$2.4M
An Integrative Bioinformatics Approach to Study Single Cancer Cell HeterogeneityK01ES025434 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GARMIRE, LANA X · 2014 to 2018
$905k
NICHD NIH HHS R01 HD084633NIEHS NIH HHS K01 ES025434NIGMS NIH HHS P20 GM103457NIGMS NIH HHS P30 GM131944NLM NIH HHS R01 LM012373
6 · The paper itself

Abstract

Identifying robust survival subgroups of hepatocellular carcinoma (HCC) will significantly improve patient care. Currently, endeavor of integrating multi-omics data to explicitly predict HCC survival from multiple patient cohorts is lacking. To fill this gap, we present a deep learning (DL)-based model on HCC that robustly differentiates survival subpopulations of patients in six cohorts. We built the DL-based, survival-sensitive model on 360 HCC patients' data using RNA sequencing (RNA-Seq), miRNA sequencing (miRNA-Seq), and methylation data from The Cancer Genome Atlas (TCGA), which predicts prognosis as good as an alternative model where genomics and clinical data are both considered. This DL-based model provides two optimal subgroups of patients with significant survival differences (

Indexed as

Biomarkers, TumorDeep LearningGenomicsMetabolomicsProteomicsAlgorithmsComputational BiologyGene Expression ProfilingGene Regulatory NetworksHumansLiver NeoplasmsPrognosisProportional Hazards ModelsReproducibility of ResultsTranscriptomeBiomarkers, Tumor

Identifiers

PMID28982688
PMCPMC6050171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.